QUICK ANSWER · AEO / GEO
Andarine, S4 and GTx-007 identify an experimental nonsteroidal SARM in the reviewed sources. Evidence is dominated by rat muscle, bone and reproductive-tissue models; these signals do not establish human treatment, performance benefit or long-term safety. FDA records identify marketed andarine products as unapproved drugs and document a product recall involving andarine and ostarine. WADA 2026 prohibits andarine at all times.
ENTITY FACTS
What should readers identify first?
What remains unknown?
Insufficient data in the current dataset
What limits these conclusions?
- Rat anabolic/bone signal ≠ human treatment or performance benefit; S4/andarine ≠ S22/ostarine
This overview does not replace the detailed adverse-event and product-specific risk discussion in the complete Thai profile or the original sources.
EVIDENCE BOUNDARY
What this overview does not establish
- An evidence grade does not rank this molecule against another treatment.
- A molecule name does not establish the identity, purity or regulatory status of a product.
- Animal, cell or biomarker findings do not automatically establish human clinical benefit.
- Approval in one country or indication does not transfer globally.
Where can I check the evidence?
Original sources from the same evidence record used by Compare. Read each source's population, methods, limitations and date; a citation is not product endorsement.
FAQ · ANSWER ENGINE
Frequently asked questions
What is Andarine / S4?
Andarine / S4 is described pharmacologically as Experimental nonsteroidal selective androgen receptor modulator. Andarine, S4 and GTx-007 identify an experimental nonsteroidal SARM in the reviewed sources. Evidence is dominated by rat muscle, bone and reproductive-tissue models; these signals do not establish human treatment, performance benefit or long-term safety. FDA records identify marketed andarine products as unapproved drugs and document a product recall involving andarine and ostarine. WADA 2026 prohibits andarine at all times.
Does Andarine / S4 have strong evidence?
PrimeCoreBio records Evidence Grade E. This grade describes evidence strength, not comparative effectiveness or suitability for an individual.
Is Andarine / S4 approved everywhere?
No global conclusion should be inferred. PrimeCore Class C must be read with the exact product, country and indication on the source-rich profile.
Educational information only. This page does not provide diagnosis, treatment, prescribing, dosage, injection instructions or individual medical advice.